Juvenile Idiopathic Arthritis (JIA) – Minors

Parents with children with Juvenile Idiopathic Arthritis (JIA) are asked to participate in a research study being conducted by Schneider Children’s Hospital.

Your child may be eligible to participate in this study if your child:

  • Is 4 to 17 years old
  • Has been diagnosed with JIA
  • Is taking Humira® or MTX therapy

Your child may not participate in this study if your child:

  • Cannot be treated with Huira®
  • Has been treated with any approved or experimental drug such as etanercept (Enbrel®), abatacept (Orencia®), infliximab (Remicade®) or rituximab (Rituxan®).
  • Has participated in another research study within the last 30 days

Contact Information

Marilynn Orlando, Study Coordinator

Schneider Children’s Hospital

269-01 76 Avenue

New Hyde Park, NY 11040

Phone: 718-470-3530

Fax: 718-831-0182

Email: Morlando@lij.edu